Annual EBIT:
-$280.56M-$48.74M(-21.02%)Summary
- As of today, AXSM annual earnings before interest & taxes is -$280.56 million, with the most recent change of -$48.74 million (-21.02%) on December 31, 2024.
- During the last 3 years, AXSM annual EBIT has fallen by -$155.85 million (-124.98%).
- AXSM annual EBIT is now -15152.91% below its all-time high of -$1.84 million, reached on December 31, 2013.
Performance
AXSM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$32.92M+$11.89M(+26.54%)Summary
- As of today, AXSM quarterly earnings before interest & taxes is -$32.92 million, with the most recent change of +$11.89 million (+26.54%) on September 30, 2025.
- Over the past year, AXSM quarterly EBIT has increased by +$13.31 million (+28.79%).
Performance
AXSM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$194.84M+$13.31M(+6.39%)Summary
- As of today, AXSM TTM earnings before interest & taxes is -$194.84 million, with the most recent change of +$13.31 million (+6.39%) on September 30, 2025.
- Over the past year, AXSM TTM EBIT has increased by +$51.03 million (+20.75%).
- AXSM TTM EBIT is now -11383.59% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AXSM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -21.0% | +28.8% | +20.8% |
| 3Y3 Years | -125.0% | +22.4% | -27.0% |
| 5Y5 Years | -318.1% | -55.8% | -103.3% |
AXSM EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -125.0% | at low | -403.7% | +56.6% | -34.6% | +25.6% |
| 5Y | 5-Year | -318.1% | at low | -403.7% | +56.6% | -106.2% | +25.6% |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | +56.6% | >-9999.0% | +25.6% |
AXSM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$32.92M(+26.5%) | -$194.84M(+6.4%) |
| Jun 2025 | - | -$44.82M(+19.2%) | -$208.15M(+13.0%) |
| Mar 2025 | - | -$55.47M(+10.0%) | -$239.22M(+5.2%) |
| Dec 2024 | -$280.56M(-21.0%) | -$61.63M(-33.3%) | -$252.44M(-2.7%) |
| Sep 2024 | - | -$46.23M(+39.1%) | -$245.87M(+6.1%) |
| Jun 2024 | - | -$75.89M(-10.5%) | -$261.94M(-6.9%) |
| Mar 2024 | - | -$68.69M(-24.7%) | -$245.06M(-34.0%) |
| Dec 2023 | -$231.82M(-28.9%) | -$55.07M(+11.6%) | -$182.91M(+0.4%) |
| Sep 2023 | - | -$62.30M(-5.6%) | -$183.56M(-12.1%) |
| Jun 2023 | - | -$59.00M(-802.8%) | -$163.71M(-13.1%) |
| Mar 2023 | - | -$6.54M(+88.3%) | -$144.75M(+18.0%) |
| Dec 2022 | -$179.80M(-44.2%) | -$55.72M(-31.2%) | -$176.50M(-15.1%) |
| Sep 2022 | - | -$42.45M(-6.0%) | -$153.39M(-6.3%) |
| Jun 2022 | - | -$40.04M(-4.6%) | -$144.34M(-6.8%) |
| Mar 2022 | - | -$38.29M(-17.4%) | -$135.15M(-8.4%) |
| Dec 2021 | -$124.71M(-24.3%) | -$32.61M(+2.4%) | -$124.71M(-4.1%) |
| Sep 2021 | - | -$33.41M(-8.3%) | -$119.84M(-11.4%) |
| Jun 2021 | - | -$30.85M(-10.8%) | -$107.56M(-13.8%) |
| Mar 2021 | - | -$27.84M(-0.4%) | -$94.49M(+4.7%) |
| Dec 2020 | -$100.33M(-49.5%) | -$27.74M(-31.3%) | -$99.14M(-3.5%) |
| Sep 2020 | - | -$21.13M(-18.8%) | -$95.83M(-2.3%) |
| Jun 2020 | - | -$17.78M(+45.3%) | -$93.65M(-4.8%) |
| Mar 2020 | - | -$32.49M(-33.0%) | -$89.32M(-32.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$67.11M(-124.9%) | -$24.43M(-28.9%) | -$67.25M(-28.7%) |
| Sep 2019 | - | -$18.95M(-40.9%) | -$52.27M(-25.8%) |
| Jun 2019 | - | -$13.45M(-29.0%) | -$41.56M(-15.1%) |
| Mar 2019 | - | -$10.42M(-10.3%) | -$36.10M(-9.9%) |
| Dec 2018 | -$29.84M(-8.1%) | -$9.45M(-14.6%) | -$32.85M(-10.1%) |
| Sep 2018 | - | -$8.24M(-3.2%) | -$29.84M(-7.0%) |
| Jun 2018 | - | -$7.99M(-11.5%) | -$27.89M(-4.6%) |
| Mar 2018 | - | -$7.16M(-11.2%) | -$26.66M(+1.9%) |
| Dec 2017 | -$27.60M(-2.0%) | -$6.44M(-2.3%) | -$27.16M(+4.2%) |
| Sep 2017 | - | -$6.30M(+6.7%) | -$28.35M(+3.1%) |
| Jun 2017 | - | -$6.75M(+12.0%) | -$29.26M(+0.3%) |
| Mar 2017 | - | -$7.67M(-0.6%) | -$29.33M(-6.5%) |
| Dec 2016 | -$27.07M(-135.9%) | -$7.63M(-5.8%) | -$27.54M(-38.3%) |
| Sep 2016 | - | -$7.21M(-5.6%) | -$19.92M(-35.2%) |
| Jun 2016 | - | -$6.83M(-16.1%) | -$14.73M(-47.5%) |
| Mar 2016 | - | -$5.88M(>-9900.0%) | -$9.99M(-63.3%) |
| Dec 2015 | -$11.47M(-109.1%) | $0.00(+100.0%) | -$6.12M(+24.1%) |
| Sep 2015 | - | -$2.02M(+2.9%) | -$8.07M(-4.2%) |
| Jun 2015 | - | -$2.08M(-3.6%) | -$7.74M(-36.9%) |
| Mar 2015 | - | -$2.01M(-3.2%) | -$5.66M(-55.2%) |
| Dec 2014 | -$5.49M(-198.4%) | -$1.95M(-14.8%) | -$3.65M(-114.8%) |
| Sep 2014 | - | -$1.70M | -$1.70M |
| Dec 2013 | -$1.84M | - | - |
FAQ
- What is Axsome Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual EBIT year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Axsome Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. TTM EBIT year-on-year change?
What is Axsome Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of AXSM is -$280.56M
What is the all-time high annual EBIT for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$1.84M
What is Axsome Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, AXSM annual earnings before interest & taxes has changed by -$48.74M (-21.02%)
What is Axsome Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AXSM is -$32.92M
What is the all-time high quarterly EBIT for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $0.00
What is Axsome Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, AXSM quarterly earnings before interest & taxes has changed by +$13.31M (+28.79%)
What is Axsome Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AXSM is -$194.84M
What is the all-time high TTM EBIT for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$1.70M
What is Axsome Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, AXSM TTM earnings before interest & taxes has changed by +$51.03M (+20.75%)